Navigation Links
QuatRx Announces Positive Results of Second Pivotal Phase 3 Clinical Study for Ophena(TM) (Ospemifene Tablets) in Treatment of Postmenopausal Vaginal Atrophy
Date:9/10/2009

ANN ARBOR, Mich., Sept. 10 /PRNewswire/ -- QuatRx Pharmaceuticals Company, a privately-held biopharmaceutical company, today announced positive efficacy results from the second of two patient cohorts in the second pivotal Phase 3 study for Ophena(TM) (ospemifene tablets), the company's investigational compound in development for the treatment of postmenopausal vulvovaginal atrophy (VVA). This study, together with the recent completion of a long-term safety study for Ophena(TM), marks the end of the company's comprehensive Phase 3 efficacy and safety program for Ophena(TM) and positions QuatRx to file a New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) in early 2010.

This second phase 3 study of Ophena(TM) was a randomized, double-blind, placebo-controlled study with 919 women with vulvovaginal atrophy. The study was conducted at 116 sites in the United States. Among the cohort of 605 women in the study who identified dyspareunia as their most bothersome symptom, positive efficacy results were achieved in all four co-primary endpoints, including decrease in parabasal and superficial cells from vaginal smear, decrease in vaginal pH and improvement in the patient's most bothersome moderate to severe symptom of dyspareunia. The results showed highly statistically significant changes from baseline to week 12 compared to placebo in all four co-primary endpoints (p<0.0001). All women were supplied with a non-hormonal vaginal lubricant to be used as needed during the treatment period and the study results demonstrated efficacy above and beyond this lubricant usage, as also observed in the first Phase 3 study.

"These findings provide substantial additional evidence indicating the potential of Ophena(TM) to be a first-in-class non-estrogen drug for the treatment of vaginal atrophy," said Robert L. Zerbe, M.D., Chief Executive Offic
'/>"/>

SOURCE QuatRx Pharmaceuticals Company
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. QuatRx Announces Further Positive Phase 3 Results For Ophena(TM) (Ospemifene Tablets) in Postmenopausal Vaginal Atrophy
2. NBTY To Web Cast Presentation at CL King Best Ideas Conference; Announces Preliminary Unaudited Net Sales Results For August 2009
3. Sambazon Announces Scientific Advisory Board
4. Echo Therapeutics Announces New Presentation Time at Rodman & Renshaw 2009 Annual Global Investment Conference
5. DSS Research Announces Outbound Education and Verification Program Meets New CMS Requirements
6. Matrox Announces the New RAD LPX Series for Medical Imaging
7. Independence Blue Cross Announces Its Second Year Sponsorship of Step Out: Walk to Fight Diabetes
8. SCAN Health Plan Announces Expansion Into Northern California
9. Teva Womens Health Announces CopewithMenopause.com Relaunch Just in Time for Menopause Awareness Month
10. FiLife Announces New Twitter Contest on Fixing the American Healthcare System
11. Regado Biosciences Announces First Patient Enrolled in RADAR (Phase 2b) Study of REG1 Anticoagulation System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... The International Concussion Organization is hosting ... Buy Theater in Times Square, New York on ... concussion epidemic that is plaguing athletes in nearly ... , The Symposium gathers more than a dozen ... athletes and legal scholars for engaging and uniquely ...
(Date:7/11/2014)... New Mexico (PRWEB) July 11, 2014 ... stress disorder are just some of the increasing numbers ... them to lead more independent and productive lives. ... the workplace? Or is an assistance dog an impediment ... Assistance Dog Week , August 3 - 9, 2014, ...
(Date:7/11/2014)... 2014 Shu Cosmetic Surgery announces ... each qualifying patient undergoing a laser vaginal ... laser vaginal rejuvenation, an advanced type of vaginal ... procedure decreases the internal and external diameters of ... strength, and control, resulting in enhanced sexual gratification ...
(Date:7/10/2014)... The Capital Institute for Neurosciences at ... procedure in a clinical trial that delivers chemotherapy to ... , During the procedure, done at Capital Health Medical ... threaded a tiny catheter through the patient’s femoral artery ... and into the brain. Once the catheter reached the ...
(Date:7/10/2014)... 10, 2014 Thousands of researchers ... Copenhagen this July 13-17 to reveal the latest ... closer to breakthroughs in dementia science. The Alzheimer’s ... conference of its kind. , As part of ... a catalyst for generating new knowledge about dementia ...
Breaking Medicine News(10 mins):Health News:The International Concussion Organization 501(c)(3) hosts its 1st Annual Concussion Symposium at the Best Buy Theater in Time Square, NYC, July 17th, 2014. 2Health News:Will Your Next Employee or Co-Worker Be a Dog? 2Health News:Will Your Next Employee or Co-Worker Be a Dog? 3Health News:Will Your Next Employee or Co-Worker Be a Dog? 4Health News:Shu Cosmetic Surgery of Twin Cities Now Offers Complimentary Perineoplasty in Laser Vaginal Rejuvenation 2Health News:Shu Cosmetic Surgery of Twin Cities Now Offers Complimentary Perineoplasty in Laser Vaginal Rejuvenation 3Health News:New Trial Delivers Chemotherapy to Brain Tumor Through Artery in Leg 2Health News:New Trial Delivers Chemotherapy to Brain Tumor Through Artery in Leg 3
... and Philadelphia, US June 17, 2008 Shire ... company, today announced the publication of data from a ... ulcerative colitis (UC) drug Lialda™ (mesalamine). The primary endpoints ... tolerability of Lialda in mild-to-moderate UC patients over 12 ...
... the 54th Summer Fancy Food Show in New York City from June ... ... WORLDFOODS provides the perfect,product for those with food allergies, are lactose ... out on,great taste. WORLDFOODS offers an exciting variety of 59 types of ...
... Patient Advocate Foundation in Supporting,Progressive, Financially Sound and ... Support by Wearing Blue and Yellow Ribbons on,June ... the,need for all patients in Tennessee to have ... strikes, Governor Phil Bredesen, for the,second consecutive year, ...
... 17 Kimberly-Clark Professional is,donating thousands of health ... residents clean up from the extensive damage caused ... was hit very hard by these storms and ... of,Kimberly-Clark Professional, North America. "At Kimberly-Clark,Professional, our mission ...
... Provide Perfect Medium for Showing Support and, Generating Awareness - ... ... SAN MATEO, Calif., June 17 CafePress, the recognized,leader in ... launched Stand Up To Cancer initiative, to raise money for,research geared ...
... July 18-20, WASHINGTON, June 17 A ... plans and health networks wrestling with,market demands for ... services., (Logo: http://www.newscom.com/cgi-bin/prnh/20030501/URACLOGO ), ... Institute, June 18-20,in San Francisco. URAC is an ...
Cached Medicine News:Health News:Long-term safety data on Lialda published in leading GI journal 2Health News:Long-term safety data on Lialda published in leading GI journal 3Health News:WORLDFOODS Provides All Natural Authentic Asian Sauces That Cater to Vegetarians, Celiacs and Those With Food Allergies 2Health News:Governor Bredesen Declares Tennessee Patient Advocacy Day to Promote Healthcare Accessibility for All 2Health News:Governor Bredesen Declares Tennessee Patient Advocacy Day to Promote Healthcare Accessibility for All 3Health News:CafePress Supports Stand Up To Cancer With Online Store to Help Raise Awareness and Funds for Research 2Health News:New URAC Issue Brief Answers Questions About Delegated Credentialing, Transparency in Physician Tiering Programs 2Health News:New URAC Issue Brief Answers Questions About Delegated Credentialing, Transparency in Physician Tiering Programs 3
(Date:1/15/2014)... WASHINGTON , Jan. 15, 2014 AARP Foundation today ... support older adults suffering from the severe cold weather that ... are committed to helping those in need; so to support ... dollar-for-dollar contributions up to $250,000, which could mean up to ...
(Date:1/15/2014)... Jan. 15, 2014 Massachusetts General Hospital (MGH), ... AMGN ) announced today that they have launched ... new therapeutic targets and develop novel therapies for ... affects millions worldwide. The MGH-Broad-Amgen collaboration brings together ...
(Date:1/15/2014)... BreedIT Corp (OTC: BRDT), through its Israeli ... sophisticated agro-breeding solutions for plant breeders and researchers, today ... of directors appointed chemistry and pharmaceutical industry expert Dr. ... the board. From 1975 to 2012, Dr. ...
Breaking Medicine Technology:AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 2AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 4BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 3
... important missions, require dependable transport ... your destination. The VIKING Guiding ... So you can set your ... not have to think about ...
Designed for young and disabled children but equally suitable for older children and adults., ,Optional 6/60 to 6/24 booklet available for patients who fail standard screening test and require fu...
... RX ACCULINK Carotid Stent System is designed to ... who have carotid atherosclerosis and are at high ... wire compatible RX ACCULINK Carotid Stent System is ... stent sizes. The RX ACCULINK utilizes rapid exchange ...
Tests for protan and deutan defects. Patients must identify numbers or patterns formed in a matrix of small colored dots varying in color and intensity. Two editions available: 38 plate for detailed ...
Medicine Products: